- Home
- PRAX vs QQQX Comparison
PRAX vs QQQX Comparison
Compare PRAX & QQQX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRAX
- QQQX
- Stock Information
- Founded
- PRAX 2015
- QQQX 2007
- Country
- PRAX United States
- QQQX United States
- Employees
- PRAX N/A
- QQQX N/A
- Industry
- PRAX Biotechnology: Pharmaceutical Preparations
- QQQX Finance Companies
- Sector
- PRAX Health Care
- QQQX Finance
- Exchange
- PRAX Nasdaq
- QQQX Nasdaq
- Market Cap
- PRAX 1.5B
- QQQX 1.3B
- IPO Year
- PRAX 2020
- QQQX N/A
- Fundamental
- Price
- PRAX $70.54
- QQQX $27.32
- Analyst Decision
- PRAX Strong Buy
- QQQX
- Analyst Count
- PRAX 9
- QQQX 0
- Target Price
- PRAX $146.33
- QQQX N/A
- AVG Volume (30 Days)
- PRAX 309.5K
- QQQX 127.6K
- Earning Date
- PRAX 03-04-2025
- QQQX 01-01-0001
- Dividend Yield
- PRAX N/A
- QQQX 7.03%
- EPS Growth
- PRAX N/A
- QQQX N/A
- EPS
- PRAX N/A
- QQQX N/A
- Revenue
- PRAX $1,605,000.00
- QQQX N/A
- Revenue This Year
- PRAX N/A
- QQQX N/A
- Revenue Next Year
- PRAX N/A
- QQQX N/A
- P/E Ratio
- PRAX N/A
- QQQX N/A
- Revenue Growth
- PRAX N/A
- QQQX N/A
- 52 Week Low
- PRAX $33.01
- QQQX $20.27
- 52 Week High
- PRAX $86.93
- QQQX $25.99
- Technical
- Relative Strength Index (RSI)
- PRAX 46.51
- QQQX 57.80
- Support Level
- PRAX $60.07
- QQQX $26.15
- Resistance Level
- PRAX $71.21
- QQQX $27.53
- Average True Range (ATR)
- PRAX 4.07
- QQQX 0.42
- MACD
- PRAX -0.79
- QQQX -0.01
- Stochastic Oscillator
- PRAX 49.11
- QQQX 84.78
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The firm's pipeline covers PRAX-114, for the treatment of a broad range of patients suffering from major depressive disorder and post-traumatic stress disorder; PRAX-944, for the treatment of Essential Tremor and Parkinson's Disease; PRAX-562, and PRAX-222, among others.
About QQQX Nuveen NASDAQ 100 Dynamic Overwrite Fund Shares of Beneficial Interest
Nuveen NASDAQ 100 Dynamic Overwrite Fund is a closed-end management investment company. Its investment objective is to seek attractive total return with less volatility than the Nasdaq 100 Index. Under normal circumstances, the Fund will invest at least 80% of its Assets in an equity portfolio made up of securities comprising the Nasdaq 100 Index (or securities that have economic characteristics that are similar to those securities comprising the Nasdaq 100 Index) that seeks to substantially replicate price movements of the Nasdaq 100 Index and is designed to support the Fund's option strategy.